🇺🇸

US SEC Filing Intelligence

· daily

All DOE Contracts — October 24, 2026

This digest covers a single Department of Energy award to Accenture Federal Services LLC: a $45,668,737 obligation under a firm-fixed-price BPA call, with a total base-plus-options value of $289,323,851 and an end date of 2032-07-27. The award is civilian (DOE, not defense), so defense-related count is 0 of 1, and the entire $45.7M falls under the civilian/energy side of federal procurement. The dominant theme is a single IT services award from DOE Headquarters Procurement Services, making the investment story narrow and contract-specific rather than sector-wide. The highest-conviction signal is the scale of potential value ($289.3M base-plus-options versus $45.7M currently obligated), which indicates a multi-year runway if options are exercised; however, conviction is tempered by $0 reported outlays, meaning no realized revenue is yet observable. The key watch item is quarterly outlay activity and option exercise against the $289.3M ceiling, and the signal is rated neutral (strength 4/10, materiality 4/10) given that the award is single, civilian, and unproven in execution.

1 total filings
· daily

High-Value Federal Grants ($5M+) — October 24, 2026

Six high-value federal awards totaling $351,510,484 were reviewed for the single-day window of October 24, 2026, though the underlying awards carry start dates ranging from 2018 to 2026. None of the six is defense-related (0/6), so the entire digest is civilian: HHS/Indian Health Service, NASA/JPL, Department of Energy, Department of Labor, and GSA. The dominant theme is civilian infrastructure, research, and administrative services rather than defense modernization, and no contract carries a clear bullish or bearish signal (all six rated neutral, average signal strength 3.0/10). The highest-materiality award is JAYNES CORPORATION's $96,728,838 firm-fixed-price design-build contract for the Alamo Navajo Health Center, though its publicly traded status is undisclosed. The principal watch item is that most of the value across the set is either unspent or contingent on option exercise, with $0 outlayed on the JAYNES, Accenture Federal, and CLEAR LINCS awards, so realized revenue impact remains unobservable.

6 total filings
· daily

DOE Energy Grants — October 24, 2026

This digest covers a single DOE award totaling $45,668,737 in obligations, all civilian and none defense-related, making the defense/civilian split 0% defense and 100% civilian (DOE). The dominant theme is a single Department of Energy IT services award to Accenture Federal Services LLC under a firm-fixed-price BPA call, with a total base-plus-options value of $289,323,851 running through 2032-07-27. The highest-conviction read is that the award is a durable, competitively awarded civilian IT vehicle, but it carries only neutral signal strength (4/10) given that current outlays are $0. The key watch item is whether the $45.7M obligation begins to outlay and whether options are exercised toward the $289.3M ceiling; the data is too thin to support a broader sector view.

1 total filings
· daily

General Federal Contracts — October 24, 2026

Six federal contracts totaling $351,510,484 in obligations were analyzed for the single-day period of October 24, 2026, all in the general federal stream with zero defense-related awards, so the entire set is civilian: HHS/Indian Health Service, NASA, DOE, Labor, and GSA. The dominant theme is civilian facilities, research, and administrative/IT services rather than defense procurement, and the highest-materiality award is JAYNES CORPORATION's $96,728,838 firm-fixed-price design-build contract for the ALAMO NAVAJO HEALTH CENTER, though the recipient's public/private status is undisclosed. All six signals are rated neutral with an average strength of 3.0/10, and no award is clearly bullish or bearish on its own. The main watch item is that three of the larger awards (JAYNES, Accenture Federal Services at $45,668,737, and CLEAR LINCS at $41,104,522) show $0 outlays, so realized revenue is unverified, and the record set does not establish any multi-year budget trend.

6 total filings
· daily

All NASA Contracts — October 24, 2026

This NASA-only digest covers 2 contract records totaling $125,476,358 in obligations, with zero defense-related awards and a civilian-only split. Both awards went to California Institute of Technology (Caltech), operating JPL as a nonprofit recipient, so the dominant theme is concentrated NASA reliance on a single JPL-affiliated research relationship rather than any publicly traded contractor. The highest-materiality award is the $75,729,570 JPL Lunar Drones delivery order (awarded 2026-04-27, running through 2028-09-24, with about 29% outlayed), while the $49,746,788 AIRS/AMSU/HSB sounding order (2018-2027) is roughly 84% spent. Because neither recipient is publicly traded and both are cost-plus, unsolicited-style awards, the investment read is neutral with no direct equity signal. The key watch item is whether option exercises or modifications push obligations toward the $76,695,487 and $52,846,176 base-plus-options ceilings.

2 total filings
· daily

Biotech Small-Cap Approvals — October 23, 2026

The October 23, 2026 digest covers 8 FDA approvals in a single-day window (classified as October 16-20 approval dates in the source data) with a mix of 0 NMEs, 0 biosimilars as true first-in-class entries, 2 label expansions, and 6 approvals classified as 'Other' (FALLBACK approval type) that the source labels as biosimilar approvals. The signal balance is 3 bullish, 0 bearish, and 5 neutral, reflecting the lack of NME-level commercial data. No dominant therapeutic area cluster emerges: the approvals span oncology (romidepsin, eribulin mesylate), neurology (brivaracetam), endocrinology/women's health (estradiol), anticoagulation (rivaroxaban), corticosteroid therapy (deflazacort), and electrolyte/critical-care products (calcium chloride, sodium citrate). The highest-conviction signal is the label expansion for rivaroxaban (YULZETY) sponsored by Rosemont Pharms, though commercial scale is NOT_DISCLOSED. The key watch item is classification integrity: the source tags six approvals as biosimilars and two as label expansions under a FALLBACK approval type, so the biosimilar designation should be verified against FDA records before any originator-erosion modeling is applied.

8 total filings
· daily

NME Blockbuster Approvals — October 23, 2026

This digest covers a single FDA action in the period October 23, 2026 to October 23, 2026, producing a mix of 0 NMEs, 0 biosimilars, 0 label expansions, and 1 other approval (a fallback-pathway action). The one approval carries a bullish signal (strength 8/10, materiality 8/10). The sole event is GlaxoSmithKline LLC's BEPIROVIRSEN (HIBSAGO), which the source data describes as an NME approval under Priority Review, though the approval type is recorded as FALLBACK and therefore the classification should be verified against the FDA action letter. No therapeutic area clustering can be established from a single event. The highest-conviction signal is GSK's BEPIROVIRSEN, where the priority review designation supports a credible commercial case, but peak sales, exclusivity term, pricing power, and market position are all NOT_DISCLOSED, leaving the investment case unquantified. The key watch item is the classification discrepancy and the absence of commercial disclosure, which limits the reliability of any sizing decision.

1 total filings
· daily

Big Pharma Approvals — October 23, 2026

This digest covers a single approval in the Big Pharma stream for the period October 23, 2026: BEPIROVIRSEN (HIBSAGO) from GlaxoSmithKline LLC, received October 20, 2026 with a bullish signal (strength 8/10, materiality 8/10). The approval mix is 0 NME, 0 biosimilar, 0 label expansion, and 1 other, so the analysis rests on one data point and no cross-approval clustering can be drawn. The record describes BEPIROVIRSEN as an NME under Priority Review, but the approval type is recorded as FALLBACK, which is an inconsistency that should be reconciled against the FDA action letter before any position is sized on it. No therapeutic area theme can be established from a single approval. The highest-conviction signal is GSK's first-cycle-style NME execution on a Priority Review, which supports sponsor execution credibility, though commercial size, exclusivity, and pricing remain NOT_DISCLOSED. The key watch item is the approval-type discrepancy together with the absence of disclosed market position and exclusivity terms.

1 total filings
· daily

New Drug Approvals (Original) — October 23, 2026

This period's digest covers 9 FDA approvals dated October 16-20, 2026, with a mix of 0 NMEs, 0 biosimilars, and 0 label expansions by the stream's classification, and 9 approvals recorded as 'Other' with fallback approval-type tagging. Signal distribution is 4 bullish and 5 neutral, with no bearish readings. The one entry carrying a 'New Molecular Entity' descriptor in its summary, BEPIROVIRSEN from GlaxoSmithKline, is the highest-conviction item (strength 8/10, materiality 8/10), though the provided data does not disclose its therapeutic area, peak sales, exclusivity, or pricing. Several summaries describe biosimilar approvals (Zydus, Kindos, Teva) and label expansions (Fresenius Medical Care, Rosemont) that conflict with the 'Other' mix classification, so these classifications should be verified against primary FDA records before any position decisions. No therapeutic area cluster can be confidently identified from the data supplied. The key watch item is classification integrity: the mismatch between summary-level descriptors and structured mix counts limits the reliability of any sector-level conclusion.

9 total filings
· daily

Federal Construction & Infrastructure Contracts — October 23, 2026

Two federal construction and infrastructure awards totaling $180,117,507 were recorded in this period, both civilian and neither defense-related (0 of 2). Clark Construction Group LLC received the larger award, a $117,000,000 firm-fixed-price CBP/DHS design-build contract for a Border Patrol Station in Las Cruces, NM, running through 2029-09-01. Veterans Development Corporation, Inc. received a $63,117,507 firm-fixed-price VA contract to replace air handling units at a Gainesville, FL facility, running through 2030-10-20 with a potential end of 2032-10-20. The dominant theme is continued civilian federal spending on border and VA facility infrastructure, but the data does not establish budget trends, and neither recipient is shown to be publicly traded. The highest-conviction signal is the scale and multi-year durability of the Clark CBP award, though its revenue contribution to the parent company cannot be determined from the data. Key watch items are the $0 outlay position on both contracts, which leaves execution pace unverified, and the unconfirmed 2026-10-21 award date for the VA contract.

2 total filings
· daily

DHS Homeland Security Contracts — October 23, 2026

Four DHS contracts totaling $291,717,811 in obligations were reviewed, all civilian with zero defense-related awards. The dominant theme is homeland security facilities and services spending across CBP, CISA, ICE, and FLETC rather than defense modernization. The largest award, Clark Construction Group LLC's $117,000,000 firm-fixed-price CBP delivery order for a Border Patrol Station in Las Cruces, NM, is the most material but carries a weak, unquantified link to parent-company revenue. The highest-conviction signal is the sole-source $83,417,225 AWS cloud hosting award from CISA, which signals durable federal cloud demand, though the data shows $0 outlayed so far. The key watch item is outlay conversion: several awards show little or no realized spending (Clark $0, AWS $0), and the SALIENT CRGT award has only $59.5M of its $154.7M base-plus-options value obligated.

4 total filings
· daily

VA Healthcare & Services Contracts — October 23, 2026

This digest covers five Department of Veterans Affairs awards totaling $1,299,738,728 in obligations, with zero defense-related contracts, so the entire stream is civilian (VA healthcare and services). The dominant value sits in one outlier: a $1,138,891,386 award to BOOZ ALLEN HAMILTON INC dated 2021-01-07, which is both the highest-materiality record and the least-documented, with pricing risk, competition, and revenue fields all marked unknown. The remaining four awards, totaling roughly $161 million, are smaller single-project or single-order contracts to VETERANS DEVELOPMENT CORPORATION, INC. ($63,117,507), SENTINEL GROUP LLC ($40,614,444), WELCH ALLYN, INC. ($30,065,118), and BLUE WATER THINKING,LLC ($27,050,270). The highest-conviction signal is the BOOZ ALLEN award's scale, but its data gaps make it a monitoring item rather than an actionable thesis, and the average signal strength of 4.6/10 reflects a predominantly neutral stream with only one bullish signal. The key watch item is date integrity: the Welch Allyn and Veterans Development awards carry award dates after the period implied by their performance or data, and the BOOZ ALLEN award is dated 2021 despite the October 2026 digest period, so record dates should be verified against official procurement sources before any position is taken.

5 total filings
· daily

New Federal Contractors — October 23, 2026

The 21 contracts in this period total $2,110,099,016 in obligations, of which only one (Lockheed Martin's $1,528,638 Coast Guard PAWSS delivery order) is defense-related, so the digest is overwhelmingly civilian. The dominant theme is civilian agency IT, facilities and program-support services spread across DHS, VA, HHS, NASA and DOJ, with no single agency-level budget trend derivable from this one-day record. The highest-materiality item is Booz Allen Hamilton's $1,138,891,386 Department of Veterans Affairs award, but the source analysis lacks revenue, pricing and competition detail, so it is treated as an unverified bullish signal rather than a high-conviction one. Most signals are neutral (20 of 21), and the one bullish signal is the Booz Allen award. The key watch item is that the record-date inconsistencies (for example Welch Allyn's award date falling after its performance period, and Veterans Development Corporation's award date sitting after the data's implied present) must be verified against official procurement records before any position is sized off these awards.

21 total filings
· daily

Significant Contract Modifications ($10M+) — October 23, 2026

The 21 significant contract modifications in this digest total $2,110,099,016 in obligations, but the headline is dominated by one award: Booz Allen Hamilton's $1,138,891,386 Department of Veterans Affairs contract, which accounts for roughly 54% of the aggregate. Only 1 of 21 records is defense-related (Lockheed Martin's $1,528,638 Coast Guard/DHS software sustainment order), so the stream is overwhelmingly civilian, spanning VA, DHS, NASA, State, EPA, DOJ, HHS and others. The dominant theme is civilian IT and professional services, with facilities and construction work from VA, DHS and NASA forming a second cluster. The highest-conviction signal is the Booz Allen VA award, though its underlying data is thin (no revenue, pricing or competition detail), so conviction is medium rather than high. The key watch item is that most records show low outlay-to-obligation ratios (several at $0), and several awards carry date inconsistencies (e.g., Welch Allyn's award date falls after its performance period), so headline obligations should not be treated as realized revenue.

21 total filings
· daily

Contract Deobligations Alert — October 23, 2026

The 21 contracts in this deobligations-alert stream total $2,110,099,016 in obligations, with only one defense-related award (1 of 21) and the rest civilian, dominated by Department of Veterans Affairs, DHS, and Department of State awards. The highest-materiality item is the Booz Allen Hamilton $1,138,891,386 Department of Veterans Affairs award, though its description, pricing, and competition fields are largely undisclosed, which limits conviction. The stream is overwhelmingly neutral (20 of 21 signals) with an average signal strength of 3.6/10, and most awards show low outlay progression, so realized revenue remains unproven for most recipients. The key watch item is whether obligated values convert into outlays and option exercises, since many contracts carry large unobligated ceilings (for example SpaceX's $7B ceiling against $127.9M obligated, and Deloitte, SAIC, and Distinction LLC with 28% to 54% of ceiling obligated). Most recipients are private or nonprofit entities, so direct public-equity exposure is limited to a few names such as Booz Allen, AWS (Amazon), Lockheed Martin, Amentum, AT&T, and ASGN.

21 total filings
· daily

Contract Option Exercises — October 23, 2026

The 21 contract option exercises in this digest total $2,110,099,016 in obligations, but this figure is dominated by a single award: Booz Allen Hamilton's $1,138,891,386 Department of Veterans Affairs contract, which accounts for roughly 54% of the total. Only 1 of the 21 records is defense-related, so the stream is overwhelmingly civilian (VA, DHS, NASA, State, EPA, DOJ, HHS, DOL, GAO), with the VA and DHS representing the most recurring agency themes. The highest-conviction signal is the Booz Allen VA award, which is the only bullish signal in the set, though its underlying scope, pricing type, and competition data are largely unknown in the record. The dominant pattern is neutral: most awards are modest, labor-based services or single-project contracts with low outlay-to-obligation progress and limited public-equity visibility, since many recipients are private LLCs or nonprofits. The key watch item is the Booz Allen contract's unverified scope and its date (2021-01-07), which sits outside this digest's stated period and should be confirmed before drawing any conclusions about its contribution.

21 total filings
· daily

Federal Professional Services Contracts — October 23, 2026

This digest covers a single federal professional services award totaling $59,511,872 in obligations, all civilian (DHS/ICE), with zero defense-related awards in the period of October 23, 2026. The dominant theme is DHS/ICE Enforcement and Removal Operations (ERO) program support, awarded to SALIENT CRGT, INC. (parent GOVCIO, LLC, Fairfax, VA) under NAICS 541330 and PSC R799. The highest-conviction observation is that the award is neutral: its $59,511,872 obligation represents only about 38% of the $154,741,529 base-plus-options value, so most of the ceiling remains unfunded and contingent on future option exercises. The key risk is that outlays of $25,277,066 cover roughly 42% of obligations, leaving realized revenue conversion unproven, and the labor-hours structure means revenue scales with staffing rather than fixed deliverables. Given the single data point and absence of revenue or public-company status data, no directional investment conviction is warranted from this period alone.

1 total filings
· daily

Federal IT & Cybersecurity Contracts — October 23, 2026

Seven federal IT and cybersecurity awards dated October 23, 2026 (stream window) carry a combined obligation of $1,406,131,752, but the record is dominated by a single $1,138,891,386 Booz Allen Hamilton award from the Department of Veterans Affairs, which is dated 2021-01-07 and therefore does not fall within the stated period, a date inconsistency that should be verified before relying on it. None of the seven awards is defense-related, so the entire stream is civilian (VA, DHS, DOJ/FBI, GAO, HHS/CDC, HHS/NIH) and the defense-sector read-through is zero. The dominant theme is civilian IT services and cloud hosting labor, with most non-Booz Allen awards in the $27M to $84M range and mostly neutral signals (6 of 7), reflecting modest, option-dependent revenue rather than step-change events. The highest-conviction signal is the Booz Allen VA award as the only bullish item, though its date and the absence of revenue, margin, and competition data limit confidence. The key watch item is option exercise and outlay pace across the group, since most awards show less than half of their potential value obligated and several have low outlay ratios, notably SAIC's GAO delivery order at roughly 19% outlaid.

7 total filings
· daily

NASA & Space Contracts Intelligence — October 23, 2026

This digest covers a single NASA & Space Contracts Intelligence record totaling $29,036,960 in obligations, with zero defense-related awards and a civilian-only split (100% NASA). The sole award is an SBIR/STTR contract to KATALYST SPACE TECHNOLOGIES, LLC dated September 19, 2025, which the source analysis rates as neutral with signal strength 4/10 and materiality 4/10. The dominant theme is civilian space R&D funded through the small business innovation pipeline, which is not a pure competitive win signal and is typically a precursor to later Phase II or III awards. The highest-conviction takeaway is limited: the record provides no revenue, pricing, competition, or moat data, so no directional equity conviction can be drawn from it. The key watch item is whether KATALYST converts this SBIR/STTR base into follow-on NASA work, and the record carries significant data gaps that limit confidence.

1 total filings
· daily

All HHS Contracts — October 23, 2026

Two HHS contracts totaling $58,031,943 in obligations were awarded in the period, with zero defense-related awards, so this digest is entirely civilian and centers on the Department of Health and Human Services. The dominant theme is IT services delivery at two agencies: the CDC awarded Deloitte Consulting LLP a $30,324,217 Time and Materials delivery order ('NCEZID IT SERVICES 3.0'), and NIH's National Cancer Institute awarded Information Management Services, Inc. a $27,707,726 cost-plus-fixed-fee delivery order under the NITAAC CIO-SP3 Small Business IDIQ. Both awards are classified neutral (average signal strength 3.5/10) because neither recipient's public revenue exposure is disclosed, and the data provides no HHS/NIH budget trend. The highest-conviction observation is that the Deloitte order has roughly 54% of its $55,806,063 base-plus-options value obligated, implying future option exercises as a durable revenue path, while Information Management Services has about one-third of its $84,401,912 ceiling obligated. The key watch item is option exercise and outlay pace, since only $14,177,877 of Deloitte's obligation and $13,510,172 of Information Management Services' obligation had been outlayed to date.

2 total filings